PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684364
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684364
Pharmaceutical Excipients Market size was valued at USD 10,237.43 Million in 2024, expanding to a CAGR of 6.96% from 2025 to 2032.
Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) in a drug. They serve various roles, such as aiding in drug delivery, enhancing stability, improving taste, and ensuring proper manufacturing.
Pharmaceutical Excipients Market- Market Dynamics
Rising demand for novel drugs delivery systems and biopharmaceuticals is expected to propel market demand
The pharmaceutical excipients market is experiencing significant growth, driven by various factors including the expansion of the pharmaceutical industry, advancements in drug formulations, and novel drug delivery systems. Traditional drug formulations are gradually being replaced by novel drug delivery systems (NDDS) such as controlled-release, sustained-release, and targeted drug delivery. These advanced drug delivery systems require specialized excipients to ensure proper drug release, stability, and effectiveness. Excipients like polymers and lipids are crucial in developing controlled-release formulations, which improve drug bioavailability and reduce dosing frequency. Additionally, emerging markets such as China, India, and Brazil are witnessing strong growth in pharmaceutical manufacturing due to lower production costs and favorable government policies.
Excipients such as sucrose, trehalose, and mannitol are used in freeze-dried biologics to maintain stability. Thus, as the demand for biopharmaceuticals continues to rise, so does the need for innovative excipients tailored for these complex formulations. Further, regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and International Council for Harmonisation (ICH) enforce strict guidelines on drug formulation, safety, and quality. To meet these standards, pharmaceutical companies are focusing on high-quality, compliant excipients that enhance drug stability and safety.
Pharmaceutical Excipients Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.96% over the forecast period (2025-2032)
Based on Product segmentation, the organic chemicals segment was predicted to show maximum market share in the year 2024, due to high demand from generic drugs.
Based on Functionality segmentation, the lubricants & glidants segment was the leading Functionality segment in 2024, due to the high need of oral solid dosages.
Based on Formulation segmentation, the oral segment was the leading Formulation segment in 2024, owing to high demand from capsule, liquid formulations.
Based on Application segmentation, the stabilizers segment was the leading Application segment in 2024, owing to high need for stabilizers in biopharmaceuticals.
On the basis of the region, Asia Pacific was the leading revenue generator in 2024, owing to large presence of pharmaceutical companies.
The Global Pharmaceutical Excipients Market is segmented on the basis of Product, Functionality, Formulation, Application, and Region.
The market is divided into two categories based on Product: organic and inorganic. The organic segment dominates the market. The increasing demand for biological drugs, novel drug delivery is expected to boost market growth.
The market is divided into seven categories based on the Functionality: fillers, binders, coating agents, colorants, disintegrants, lubricants & glidants, and others. The lubricants & glidants segment is expected to hold the largest share due to the high demand from oral dosages.
The market is divided into four categories based on Formulation: oral, topical, parenteral, and others. The oral segment is expected to hold the largest share. The wider usage & its efficacy against different ailments is contributing to segment demand.
The market is divided into three categories based on Application: stabilizers, taste masking, and others. The stabilizers segment holds the highest share of the application segment. The increasing demand from generic drug production, high quality excipients is accelerating segment growth.
Pharmaceutical Excipients Market- Geographical Insights
Across the world, the Pharmaceutical Excipients market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global pharmaceutical excipients market. The U.S. is home to a robust pharmaceutical sector, including many generic drug manufacturers and biopharmaceutical companies. This contributes to the growing demand for excipients. Europe is at the forefront of innovative drug formulations, particularly in the areas of biopharmaceuticals and vaccines, which require specialized excipients. With an aging population in Europe, there is a growing need for drugs that cater to chronic diseases, driving the demand for pharmaceutical excipients, especially in oral drug formulations. Asia-Pacific is becoming a hub for contract manufacturing of pharmaceuticals, particularly in India and China.
The pharmaceutical excipients market is highly competitive, with numerous global and regional players engaged in the production and supply of a wide range of excipients. These excipients play a critical role in drug formulation, enhancing stability, bioavailability. Market players focus on offering excipients that are used in a wide variety of drug formulations, including controlled-release, bioavailability enhancers, and drug solubilizers. Companies are focusing on R&D and innovation to develop new excipients that improve drug performance. Excipients that can enable sustained-release, controlled-release, and bioavailability enhancement are in high demand. The company's strong research and development (R&D) capabilities allow it to offer tailored solutions for customers.
In 2023, BASF collaborated with Croda International Plc to develop and market new excipients aimed at improving drug delivery in oral and parenteral formulations.
In 2024, Roquette Freres has focused on developing plant-based excipients that cater to the growing consumer preference for natural ingredients.